Dr Ontaneda introduces Neurodiem’s Digital Health section, and reviews the impact of digital technologies on research and practice
Discover Digital Health at Neurodiem
Dr Daniel Ontaneda has reported the following commercial interests occurring within the past 12 months:
• Consultant/advisor: Genentech, Novartis, BMS, Biogen Idec
• Research grant: Genentech, Novartis